Regis Healthcare Limited (ASX:REG) Announces Half-Year Financial Results
Regis Healthcare Limited (ASX:REG) reports a 17.5% revenue increase and $24.36 million profit for the half-year, announces an interim dividend and strategic acquisitions.
Category: Healthcare
nib Holdings Limited (ASX:NHF) Announces 1H25 Results
nib Holdings Limited (ASX:NHF) reports 1H25 revenues up 7.7%, net profit declines and declares a 13c interim dividend.
Anatara Lifesciences (ASX:ANR) Advances GaRP-IBS Trial and Launches Anti-Obesity Project
Anatara Lifesciences (ASX:ANR) advances its GaRP-IBS trial towards completion and launches a new anti-obesity project with ethics approval.
Vitura Health Limited (ASX:VIT) Completes Acquisition of Candor Medical
Vitura Health Limited (ASX:VIT) completes the acquisition of Candor Medical, expanding its digital health services and enhancing shareholder value.
Healius Limited (ASX:HLS) Announces Half Year Results
Healius Limited (ASX:HLS) reports a 10% revenue increase in 1H25, highlights strong EBIT growth and plans to sell Lumus Imaging.
Healius Limited (ASX:HLS) Releases Independent Auditor’s Review Report
Healius Limited (ASX:HLS) releases an independent auditor’s review confirming compliance with key regulations and accounting standards.
Wellnex Life Limited (ASX:WNX) Secures $14.3M for AIM Dual Listing
Wellnex Life Limited (ASX:WNX) secures $14.3 million for AIM dual listing, supporting debt redemption and acquisition payments.
Sonic Healthcare Limited (ASX:SHL) Reports H1 2024 Results
Sonic Healthcare Limited (ASX:SHL) reports an 8.4% revenue increase and a 17% profit rise in H1 2024, alongside a 2.3% interim dividend hike.
Nanosonics Limited (ASX:NAN) Announces 2025 Half-Year Financial Results
Nanosonics (ASX:NAN) reports an 18% revenue increase in its 2025 half-year, highlighting strong growth and future outlook.
Oakridge International Limited (ASX:OAK) Releases Half-Year Financial Report
Oakridge International Limited (ASX:OAK) reports a 109% revenue increase and a 72% reduction in loss for the half-year ended 31 December 2024.